Hepatobiliary & Pancreatic Diseases International最新文献

筛选
英文 中文
Chinese contributions to liver transplantation. 中国对肝移植的贡献。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-11-01 DOI: 10.1016/j.hbpd.2024.10.005
Jan Lerut
{"title":"Chinese contributions to liver transplantation.","authors":"Jan Lerut","doi":"10.1016/j.hbpd.2024.10.005","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.005","url":null,"abstract":"","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"No-donor" liver transplantation. "无捐献 "肝脏移植。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-11-01 DOI: 10.1016/j.hbpd.2024.10.006
Yong-Fa Huang, Zhi-Jun Zhu
{"title":"\"No-donor\" liver transplantation.","authors":"Yong-Fa Huang, Zhi-Jun Zhu","doi":"10.1016/j.hbpd.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.006","url":null,"abstract":"<p><p>Liver transplantation is hindered by organ shortage. The potential way to relieve this issue is to expand the donor pool via extending the donor criteria and make full use of all available grafts. The concept of \"no-donor\" liver transplantation allows grafts to be recovered from other liver recipients. This review summarizes the current clinical practice of \"no-donor\" liver transplantation, focusing on the experiences of Chinese transplant teams. Domino liver transplantation was introduced by Furtado in 1995 and implemented later in 2013 in China, and novel donor indications including some essential-to-treat inherited metabolic liver-based diseases have emerged. The concept of cross-auxiliary domino liver transplantation brings a further expansion of the domino liver graft pool, and the first pair of liver transplantation performed \"rigorously without donation\" was accomplished in our center in 2018. Our experience with this original transplantation procedure is hereby reviewed. In order to further promote and make successful \"no-donor\" liver transplantation, close co-operation between researchers, surgeons, physicians, organ procurement organizations, as well as ethical committees is required.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No-touch recipient hepatectomy in liver transplantation for liver malignancies: A state-of-the-art review. 肝脏恶性肿瘤肝移植中的无接触受体肝切除术:最新进展回顾。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-28 DOI: 10.1016/j.hbpd.2024.10.004
Sheng-Jun Xu, Qiang Wei, Xin Hu, Chang-Biao Li, Zhe Yang, Shu-Sen Zheng, Xiao Xu
{"title":"No-touch recipient hepatectomy in liver transplantation for liver malignancies: A state-of-the-art review.","authors":"Sheng-Jun Xu, Qiang Wei, Xin Hu, Chang-Biao Li, Zhe Yang, Shu-Sen Zheng, Xiao Xu","doi":"10.1016/j.hbpd.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.004","url":null,"abstract":"<p><p>Tumor recurrence, the Gordian knot of liver transplantation for malignancies, may be attributed to many parameters. The technique of the \"classical\" recipient hepatectomy is believed to be one of the potential reasons to cause tumor evasion because of the possible increase of circulating tumor cells, thus leading to an increased recurrent rate. On this background, the no-touch oncological recipient hepatectomy technique has been developed. A comprehensive review of the development and the key surgical steps of the no-touch recipient hepatectomy is presented. This technique might improve clinical outcomes, especially for those recipients who are at a high risk for tumor recurrence. Multicenter prospective studies should be set up to further validate the prognostic role of this technique in patients with liver cancer treated with liver transplantation.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequential living donor liver transplantation after liver resection optimizes outcomes for patients with high-risk hepatocellular carcinoma. 肝脏切除术后进行序贯活体肝移植可优化高危肝细胞癌患者的预后。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-22 DOI: 10.1016/j.hbpd.2024.10.003
Itsuko Chih-Yi Chen, Leona Bettina P Dungca, Chee-Chien Yong, Chao-Long Chen
{"title":"Sequential living donor liver transplantation after liver resection optimizes outcomes for patients with high-risk hepatocellular carcinoma.","authors":"Itsuko Chih-Yi Chen, Leona Bettina P Dungca, Chee-Chien Yong, Chao-Long Chen","doi":"10.1016/j.hbpd.2024.10.003","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.003","url":null,"abstract":"<p><strong>Background: </strong>Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. While liver transplantation (LT) provides the best long-term survival, it is constrained by organ scarcity and strict criteria. Liver resection (LR) is often the initial treatment for patients with solitary tumors and preserved liver function. The high recurrence rates associated with LR has prompted the exploration of sequential living donor liver transplantation (seqLDLT) after LR as a strategy for HCC patients with high-risk of recurrence.</p><p><strong>Methods: </strong>We analyzed data from 27 adult patients who underwent seqLDLT after LR for HCC at Kaohsiung Chang Gung Memorial Hospital (KCGMH) between June 1994 and December 2023. Patients were selected based on high-risk histopathological features post-LR or as part of downstaging strategy. Outcomes measured included overall survival (OS) and disease-free survival (DFS).</p><p><strong>Results: </strong>Among 765 HCC patients who underwent LDLT, 204 received LR before LDLT, and 27 underwent seqLDLT. Five patients (19%) underwent living donor liver transplantation (LDLT) following LR as a downstaging strategy while the rest received seqLDLT as a preemptive strategy. The median age was 53.5 years with 85% males. Chronic hepatitis B was the predominant underlying disease (74%). The 1-, 3-, and 5-year OS and DFS rates were 100%, 96.0%, 96.0% and 100%, 96.2%, 96.2%, respectively, with two patients experiencing HCC recurrence. One patient died from HCC recurrence. High-risk histopathological features included microvascular invasion (52%), satellite nodules (15%), multiple tumors (26%), tumors > 5 cm (19%), and a total tumor diameter > 10 cm (7%).</p><p><strong>Conclusions: </strong>SeqLDLT offers a promising, tailored approach for managing HCC with adverse histopathologic features. Combining seqLDLT, downstaging strategies, and multidisciplinary treatments can achieve satisfactory OS and DFS in carefully selected patients, highlighting the need for refined criteria to identify the best candidates.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of ischemia-free liver transplantation. 无缺血肝移植的研究进展。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-22 DOI: 10.1016/j.hbpd.2024.10.002
Ming-Xi Zhang, Qiang Zhao, Xiao-Shun He
{"title":"Research progress of ischemia-free liver transplantation.","authors":"Ming-Xi Zhang, Qiang Zhao, Xiao-Shun He","doi":"10.1016/j.hbpd.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.002","url":null,"abstract":"<p><p>Ischemia-reperfusion injury (IRI) is an inherent issue in organ transplantation. Because of the allograft shortage, more and more extended criteria donor (ECD) organs are used, unfortunately these grafts are more susceptible to IRI. Although machine perfusion technology has brought hope to alleviate IRI, this technology is still unable to eradicate IRI-related organ damage. Ischemia-free liver transplantation (IFLT) can completely avoid IRI, thereby improve graft function and recipient outcome, and allow to expand organ pool. This review summarized the latest progresses in IFLT, and speculated the future development of this concept.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese expert consensus on quantitatively monitoring and assessing immune cell function status and its clinical application (2024 edition). 免疫细胞功能状态定量监测与评估及其临床应用中国专家共识(2024 年版)》。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-15 DOI: 10.1016/j.hbpd.2024.10.001
Lin Zhou, Ji-Qiao Zhu, Jian-Tao Kou, Wen-Li Xu, Shao-Cheng Lyu, Guo-Sheng Du, Hong-Wei Yang, Jian-Feng Wang, Xiao-Peng Hu, Chun-Zhao Yu, Chun-Hui Yuan, Dong-Dong Han, Cui-Qin Sang, Bo Li, Jie Gao, Hai-Zhi Qi, Li-Ming Wang, Ling Lyu, Hao Liu, Jian-Yong Wu, Ren Lang, Qiang He, Xian-Liang Li
{"title":"Chinese expert consensus on quantitatively monitoring and assessing immune cell function status and its clinical application (2024 edition).","authors":"Lin Zhou, Ji-Qiao Zhu, Jian-Tao Kou, Wen-Li Xu, Shao-Cheng Lyu, Guo-Sheng Du, Hong-Wei Yang, Jian-Feng Wang, Xiao-Peng Hu, Chun-Zhao Yu, Chun-Hui Yuan, Dong-Dong Han, Cui-Qin Sang, Bo Li, Jie Gao, Hai-Zhi Qi, Li-Ming Wang, Ling Lyu, Hao Liu, Jian-Yong Wu, Ren Lang, Qiang He, Xian-Liang Li","doi":"10.1016/j.hbpd.2024.10.001","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.10.001","url":null,"abstract":"","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and effectiveness of balloon catheter-assisted ultrasound-guided percutaneous microwave ablation in difficult-site liver cancer. 球囊导管辅助超声引导经皮微波消融术治疗疑难部位肝癌的安全性和有效性。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-04 DOI: 10.1016/j.hbpd.2024.09.012
Qi-Yu Zhao, Teng Guo, Jing-Jing Hu, Li-Ting Xie, Wei-Lu Chai, Guo Tian, Tian-An Jiang
{"title":"Safety and effectiveness of balloon catheter-assisted ultrasound-guided percutaneous microwave ablation in difficult-site liver cancer.","authors":"Qi-Yu Zhao, Teng Guo, Jing-Jing Hu, Li-Ting Xie, Wei-Lu Chai, Guo Tian, Tian-An Jiang","doi":"10.1016/j.hbpd.2024.09.012","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.09.012","url":null,"abstract":"<p><strong>Background: </strong>Balloon catheter isolation is a promising auxiliary method for thermal ablation treatment of liver cancer. We aimed to explore the safety and effectiveness of balloon catheter isolation-assisted ultrasound-guided percutaneous microwave ablation (MWA) in treating liver cancer in difficult anatomical locations.</p><p><strong>Methods: </strong>Data of 132 patients with 145 difficult-site liver cancer treated with ultrasound-guided percutaneous MWA were retrospectively analyzed. Participants were classified into the isolation (n = 40) and non-isolation (n = 92) groups based on whether the patients were treated using a balloon catheter prior to ablation. The major complication rates, local tumor residuals (LTR), and tumor follow-up for local tumor progression (LTP) at 6 and 12 months post-ablation were compared between the two groups.</p><p><strong>Results: </strong>The rates of major postoperative complications did not significantly differ between the isolation and non-isolation groups (2.5% vs. 4.3%, P = 0.609). The postoperative LTR rates were significantly different between the isolation and non-isolation groups (4.8% vs. 17.5%, P = 0.032). Balloon catheter isolation [odds ratio (OR) = 0.225, 95% confidence interval (CI): 0.085-0.595, P = 0.009] and tumor diameter (OR = 2.808, 95% CI: 1.186-6.647, P = 0.019) were identified as independent factors influencing LTR rate. The cumulative LTP rates at 6 and 12 months after ablation showed no significant differences between the isolation and non-isolation groups (2.6% vs. 7.9%, P = 0.661; 4.9% vs. 9.8%, P = 0.676, respectively). Cox proportional hazards regression analysis showed that tumor diameter was an independent risk factor for cumulative LTP rate (OR = 3.445, 95% CI: 1.406-8.437, P = 0.017).</p><p><strong>Conclusions: </strong>Balloon catheter isolation-assisted MWA was safe and effective in the treatment of difficult-site liver cancer. Additionally, tumor diameter significantly influenced LTR and LTP rates after ablation.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances and current research status of early diagnosis for gallbladder cancer. 胆囊癌早期诊断的进展和研究现状。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-04 DOI: 10.1016/j.hbpd.2024.09.011
Jia-Jia He, Wei-Lv Xiong, Wei-Qi Sun, Qun-Yan Pan, Li-Ting Xie, Tian-An Jiang
{"title":"Advances and current research status of early diagnosis for gallbladder cancer.","authors":"Jia-Jia He, Wei-Lv Xiong, Wei-Qi Sun, Qun-Yan Pan, Li-Ting Xie, Tian-An Jiang","doi":"10.1016/j.hbpd.2024.09.011","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.09.011","url":null,"abstract":"<p><p>Gallbladder cancer (GBC) is the most common malignant tumor in the biliary system, characterized by high malignancy, aggressiveness, and poor prognosis. Early diagnosis holds paramount importance in ameliorating therapeutic outcomes. Presently, the clinical diagnosis of GBC primarily relies on clinical-radiological-pathological approach. However, there remains a potential for missed diagnosis and misdiagnose in the realm of clinical practice. We firstly analyzed the blood-based biomarkers, such as carcinoembryonic antigen and carbohydrate antigen 19-9. Subsequently, we evaluated the diagnostic performance of various imaging modalities, including ultrasound (US), endoscopic ultrasound (EUS), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) and pathological examination, emphasizing their strengths and limitations in detecting early-stage GBC. Furthermore, we explored the potential of emerging technologies, particularly artificial intelligence (AI) and liquid biopsy, to revolutionize GBC diagnosis. AI algorithms have demonstrated improved image analysis capabilities, while liquid biopsy offers the promise of non-invasive and real-time monitoring. However, the translation of these advancements into clinical practice necessitates further validation and standardization. The review highlighted the advantages and limitations of current diagnostic approaches and underscored the need for innovative strategies to enhance diagnostic accuracy of GBC. In addition, we emphasized the importance of multidisciplinary collaboration to improve early diagnosis of GBC and ultimately patient outcomes. This review endeavoured to impart fresh perspectives and insights into the early diagnosis of GBC.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142407216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nomogram for prediction of severe postoperative complications in elective hepato-pancreato-biliary surgery after COVID-19 breakthrough infection: A large multicenter study. 用于预测 COVID-19 突破性感染后肝胆胰择期手术严重术后并发症的提名图:大型多中心研究。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-02 DOI: 10.1016/j.hbpd.2024.09.009
Yun Yang, Zheng Dang, Liang Tang, Peng Lu, Shang Ma, Jin Hou, Ze-Ya Pan, Wan Yee Lau, Wei-Ping Zhou
{"title":"Nomogram for prediction of severe postoperative complications in elective hepato-pancreato-biliary surgery after COVID-19 breakthrough infection: A large multicenter study.","authors":"Yun Yang, Zheng Dang, Liang Tang, Peng Lu, Shang Ma, Jin Hou, Ze-Ya Pan, Wan Yee Lau, Wei-Ping Zhou","doi":"10.1016/j.hbpd.2024.09.009","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.09.009","url":null,"abstract":"<p><strong>Background: </strong>Currently, there is a deficiency in a strong risk prediction framework for precisely evaluating the likelihood of severe postoperative complications in patients undergoing elective hepato-pancreato-biliary surgery subsequent to experiencing breakthrough infection of coronavirus disease 2019 (COVID-19). This study aimed to find factors predicting postoperative complications and construct an innovative nomogram to pinpoint patients who were susceptible to developing severe complications following breakthrough infection of COVID-19 after undergoing elective hepato-pancreato-biliary surgery.</p><p><strong>Methods: </strong>This multicenter retrospective cohort study included consecutive patients who underwent elective hepato-pancreato-biliary surgeries between January 3 and April 1, 2023 from four hospitals in China. All of these patients had experienced breakthrough infection of COVID-19 prior to their surgeries. Additionally, two groups of patients without preoperative COVID-19 infection were included as comparative controls. Surgical complications were meticulously documented and evaluated using the comprehensive complication index (CCI), which ranged from 0 (uneventful course) to 100 (death). A CCI value of 20.9 was identified as the threshold for defining severe complications.</p><p><strong>Results: </strong>Among 2636 patients who were included in this study, 873 were included in the reference group I, 941 in the reference group II, 389 in the internal cohort, and 433 in the external validation cohort. Multivariate logistic regression analysis revealed that completing a full course of COVID-19 vaccination > 6 months before surgery, undergoing surgery within 4 weeks of diagnosis of COVID-19 breakthrough infection, operation duration of 4 h or longer, cancer-related surgery, and major surgical procedures were significantly linked to a CCI > 20.9. A nomogram model was constructed utilizing CCI > 20.9 in the training cohort [area under the curve (AUC): 0.919, 95% confidence interval (CI): 0.881-0.957], the internal validation cohort (AUC: 0.910, 95% CI: 0.847-0.973), and the external validation cohort (AUC: 0.841, 95% CI: 0.799-0.883). The calibration curve for the probability of CCI > 20.9 demonstrated good agreement between the predictions made by the nomogram and the actual observations.</p><p><strong>Conclusions: </strong>The developed model holds significant potential in aiding clinicians with clinical decision-making and risk stratification for patients who have experienced breakthrough infection of COVID-19 prior to undergoing elective hepato-pancreato-biliary surgery.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplantation using an otherwise-wasted partial liver resection graft. 利用原本已浪费的部分肝切除移植物进行肝移植。
IF 3.6 3区 医学
Hepatobiliary & Pancreatic Diseases International Pub Date : 2024-10-02 DOI: 10.1016/j.hbpd.2024.09.008
Yong-Sheng Xiao, Yi-Feng He, Xiao-Wu Huang, Zhao-You Tang, Jia Fan, Jian Zhou
{"title":"Liver transplantation using an otherwise-wasted partial liver resection graft.","authors":"Yong-Sheng Xiao, Yi-Feng He, Xiao-Wu Huang, Zhao-You Tang, Jia Fan, Jian Zhou","doi":"10.1016/j.hbpd.2024.09.008","DOIUrl":"https://doi.org/10.1016/j.hbpd.2024.09.008","url":null,"abstract":"<p><p>Liver transplantation represents a complex surgical procedure and serves as a curative treatment for patients presenting an acute or chronic end-stage liver disease, or carefully selected liver malignancy. A significant gap still exists between the number of available donor organs and potential recipients. The use of an otherwise-wasted resected liver lobe from patients with benign liver tumors is a new, albeit small, option to alleviate the allograft shortage. This review provides evidence that resected liver lobes may be used successfully in liver transplantation.</p>","PeriodicalId":55059,"journal":{"name":"Hepatobiliary & Pancreatic Diseases International","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信